- Home
- CLLS vs GCO Comparison
CLLS vs GCO Comparison
Compare CLLS & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- GCO
- Stock Information
- Founded
- CLLS 1999
- GCO 1924
- Country
- CLLS France
- GCO United States
- Employees
- CLLS N/A
- GCO N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- GCO Clothing/Shoe/Accessory Stores
- Sector
- CLLS Health Care
- GCO Consumer Discretionary
- Exchange
- CLLS Nasdaq
- GCO Nasdaq
- Market Cap
- CLLS 299.0M
- GCO 321.1M
- IPO Year
- CLLS 2007
- GCO N/A
- Fundamental
- Price
- CLLS $3.22
- GCO $31.23
- Analyst Decision
- CLLS Buy
- GCO Buy
- Analyst Count
- CLLS 1
- GCO 3
- Target Price
- CLLS $8.00
- GCO $32.67
- AVG Volume (30 Days)
- CLLS 134.5K
- GCO 82.8K
- Earning Date
- CLLS 11-07-2025
- GCO 12-05-2025
- Dividend Yield
- CLLS N/A
- GCO N/A
- EPS Growth
- CLLS N/A
- GCO N/A
- EPS
- CLLS N/A
- GCO N/A
- Revenue
- CLLS $63,438,000.00
- GCO $2,362,215,000.00
- Revenue This Year
- CLLS N/A
- GCO $4.60
- Revenue Next Year
- CLLS $58.00
- GCO $2.14
- P/E Ratio
- CLLS N/A
- GCO N/A
- Revenue Growth
- CLLS 223.09
- GCO 2.66
- 52 Week Low
- CLLS $1.10
- GCO $16.19
- 52 Week High
- CLLS $5.48
- GCO $44.80
- Technical
- Relative Strength Index (RSI)
- CLLS 41.41
- GCO 56.92
- Support Level
- CLLS $3.12
- GCO $27.85
- Resistance Level
- CLLS $3.79
- GCO $31.27
- Average True Range (ATR)
- CLLS 0.19
- GCO 1.16
- MACD
- CLLS -0.08
- GCO 0.19
- Stochastic Oscillator
- CLLS 13.43
- GCO 75.97
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.